This is another follow up to this post where I introduced my concept for evaluating undervalued LPs. While this does not take all things into account, such as global distribution plans and ancillary businesses, it does give some insight worth looking at.

Over the last while there have been large market moves, several equity raises and some news developments, so let’s check in on the data and see how the LPs stack up. In the last post, the number one position was held by THCX, which has since moved up the list after seeing some share price appreciation, as of the last post it was $3.81 but has seen substantial volatility along with the rest of the sector.

Here is the current top 5, the complete dynamic list is available to members here

As of this writing, the author holds a position in GENE

Save valuable time

Stop scouring the internet looking for company information.